Components of a complex substance
Pharmacological Group
Latin name
Cliochinolum + Prednisolonum ( сliochinoli + Prednisoloni).
Used in the treatment
- S05 Injury of eye and orbit
- R57.9 Shock, unspecified
- R21 Rash and other nonspecific skin eruption
- R11 Nausea and vomiting
- N04 Nephrotic syndrome
- N00 Acute nephritic syndrome
- M77.9 Enthesopathy, unspecified
- M75.0 Adhesive capsulitis of shoulder
- M71.9 Bursopathy, unspecified
- M65.9 Synovitis and tenosynovitis, unspecified
- M54.3 Sciatica
- M47.9 Spondylosis, unspecified
- M45 Ankylosing spondylitis
- M34 Systemic sclerosis
- M33.2 Polymyositis
- M32 Systemic lupus erythematosus
- M31.1 Thrombotic microangiopathy
- M30.0 Polyarteritis nodosa
- M19.9 Arthrosis, unspecified
- M13.0 Polyarthritis, unspecified
- M10.0 Idiopathic gout
- M08 Juvenile arthritis
- M06.9 Rheumatoid arthritis, unspecified
- M06.1 Adult-onset Still's disease
- L98.8 Other specified disorders of skin and subcutaneous tissue
- L93.0 Discoid lupus erythematosus
- L91.0 Hypertrophic scar
- L65.9 Nonscarring hair loss, unspecified
- L53 Other erythematous conditions
- L51.2 Toxic epidermal necrolysis [Lyell]
- L50 Urticaria
- L40.5 Arthropathic psoriasis (M07.0-M07.3*, M09.0*)
- L40 Psoriasis
- L30.9 Dermatitis, unspecified
- L28.0 Lichen simplex chronicus
- L26 Exfoliative dermatitis
- L25.9 Unspecified contact dermatitis, unspecified cause
- L21 Seborrhoeic dermatitis
- L20.8 Other atopic dermatitis
- L20 Atopic dermatitis
- L13.9 Bullous disorder, unspecified
- L10 Pemphigus
- K74 Fibrosis and cirrhosis of liver
- K73.9 Chronic hepatitis, unspecified
- K72.0 Acute and subacute hepatic failure
- K51 Ulcerative colitis
- K50 Crohn's disease [regional enteritis]
- J84.1 Other interstitial pulmonary diseases with fibrosis
- J82 Pulmonary eosinophilia, not elsewhere classified
- J69.0 Pneumonitis due to food and vomit
- J63.2 Berylliosis
- J46 Status asthmaticus
- J45 Asthma
- J30 Vasomotor and allergic rhinitis
- J18.9 Pneumonia, unspecified
- I25.2 Old myocardial infarction
- I00 Rheumatic fever without mention of heart involvement
- I01 Rheumatic fever with heart involvement
- H46 Optic neuritis
- H44.1 Other endophthalmitis
- H30 Chorioretinal inflammation
- H20 Iridocyclitis
- H16.8 Other keratitis
- H16.0 Corneal ulcer
- H15.1 Episcleritis
- H15.0 Scleritis
- H10.9 Conjunctivitis, unspecified
- H10.5 Blepharoconjunctivitis
- H10.1 Acute atopic conjunctivitis
- H01.0 Blepharitis
- G93.6 Cerebral oedema
- G35 Multiple sclerosis
- E83.5.0* Hypercalcemia
- E27.8 Other specified disorders of adrenal gland
- E27.4 Other and unspecified adrenocortical insufficiency
- E27.1 Primary adrenocortical insufficiency
- E06.1 Subacute thyroiditis
- E05.5 Thyroid crisis or storm
- E05 Thyrotoxicosis [hyperthyroidism]
- D86.0 Sarcoidosis of lung
- D70 Agranulocytosis
- D69.5 Secondary thrombocytopenia
- D69.3 Idiopathic thrombocytopenic purpura
- D61.9 Aplastic anaemia, unspecified
- D61.0 Constitutional aplastic anaemia
- D60.9 Acquired pure red cell aplasia, unspecified
- D59.1 Other autoimmune haemolytic anaemias
- C92 Myeloid leukaemia
- C91 Lymphoid leukaemia
- C81 Hodgkin lymphoma
- C34 Malignant neoplasm of bronchus and lung
- A17.0 Tuberculous meningitis (G01*)
- A16 Respiratory tuberculosis, not confirmed bacteriologically or histologically
- A09 Other gastroenteritis and colitis of infectious and unspecified origin
- T78.0 Anaphylactic shock due to adverse food reaction
- T78.1 Other adverse food reactions, not elsewhere classified
- T78.3 Angioneurotic oedema
- T78.4 Allergy, unspecified
- T80.6 Other serum reactions
- Y40-Y59 Medicinal products, medicines and biological substances that cause adverse reactions during therapeutic use
- Z94 Transplanted organ and tissue status
- T49.8 Poisoning, other topical agents
- M30-M36 Systemic connective tissue lesions
- L12 Pemphigoid
- I32 Pericarditis in diseases classified elsewhere
- I30 Acute pericarditis
- D64 Other anaemias
- B15-B19 Viral hepatitis
- T52.9 Toxic effect, organic solvent, unspecified
- Y84.3 Abnormal reaction/later complication, shock therapy
- T54.9 Toxic effect, corrosive substance, unspecified